by DV Schaardenburg, et al.
June 2, 2007
[Note: The C-reactive protein is a general marker of infection and inflammation. CRP tests are typically used to monitor patients after surgery or track the results of treatment.]
Journal: Nature Clinical Practice Rheumatology. 2007. 3, 318-319.
Authors and affiliation: Schaardenburg DV, Wolbink G, Nurmohamed MT, Dijkmans BAC. Jan van Breemen Institute, Department of Rheumatology, Amsterdam, The Netherlands. [E-mail: d.v.schaardenburg@janvanbreemen.nl ]
PMID: 17437031
This article has no abstract so we have provided the first paragraph of the full text.
Insight into the preclinical [before symptoms] phase of RA (which can often last several years) is exciting, as it might provide insight into the early pathogenetic events that could be obscured in the clinical phase of the disease by the intense inflammatory process.
The ability to treat RA preclinically, and possibly with a less intensive and shorter regimen than is needed for overt polyarthritis [involvement of five or more joints], is an appealing prospect.
|
